VBI Vaccines (VBIV)
(Delayed Data from NSDQ)
$0.62 USD
-0.01 (-1.56%)
Updated Apr 22, 2024 11:39 AM ET
After-Market: $0.60 -0.02 (-3.82%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.53 | 0.00% |
Earnings Summary
For their last quarter, VBI Vaccines (VBIV) reported earnings of -$0.38 per share, missing the Zacks Consensus Estimate of -$0.14 per share. This reflects a negative earnings surprise of 171.43%. Look out for VBIV's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.53 per share, reflecting a year-over-year increase of 78.19%.
Earnings History
Price & Consensus
Zacks News for VBIV
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Lags Revenue Estimates
VBIV: What are Zacks experts saying now?
Zacks Private Portfolio Services